SCHEMBL20127439

SCHEMBL20127439

c1ccc2c(-c3c4ccccc4c(-c4cccc5c4ccc4ccccc45)c4ccccc34)c3oc4ccccc4c3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.46
ALDH1A1 P00352 2/20 0.40
HIF1A Q16665 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP1B1 Q16678 1/20 0.40
ALOX5 P09917 2/20 0.39
HPRT1 P00492 2/20 0.38
AHR P35869 2/20 0.37
HPGD P15428 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127446 0.93 SOS1 (0.39) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL10122563 0.93 ALOX5 (0.41) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL20127637 0.92 ALOX5 (0.40) SOS1ALDH1A1HIF1AHSD17B10ALOX5
SCHEMBL20127445 0.90 ALDH1A1 (0.46) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL10122560 0.89 AHR (0.41) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL20127437 0.88 SOS1 (0.39) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL20127640 0.88 ALOX5 (0.38) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL20127457 0.87 ALOX5 (0.48) SOS1ALDH1A1HSD17B10ALOX5AHR
SCHEMBL17943907 0.87 ALOX5 (0.44) SOS1ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL21984296 0.86 ALOX5 (0.40) SOS1ALDH1A1HSD17B10CYP1B1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 SOS1 960/4885ALDH1A1 476/4885HIF1A 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.